Itonis, Inc. (ITNS)
Itonis, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Laguna Hills, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $609,364. On trailing twelve-month figures it carries a trailing P/E of -53.86, a net margin of -15224.1%. Its beta of 0.26 implies it has historically moved less than the broad market.
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Itonis, Inc. is most often compared with the following Healthcare names: